Hyderabad: India is a step closer to getting the first naval COVID-19 vaccine.
Clinical phase 3 trials of Bharat Biotech’s COVID-19 nasal vaccine have been completed, and the Hyderabad-based company will soon be submitting its data to Drugs Controller General of India (DCGI) next month.
“We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine,” Bharat Biotech Chairman and MD Dr Krishna Ella told ANI.
DCGI had granted permission to Bharat Biotech to conduct standalone phase 3 trials in January.
Dr Ella was in Paris as a speaker at Viva Technology 2022, where India was declared country of the year.
“I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997,” Dr Ella said.
New Delhi: India and Pakistan on Saturday advised students in Bishkek "to stay indoors" amid…
New Delhi: In a twist to the alleged Swati Maliwal case, Arvind Kejriwal's aide, Bibhav…
New Delhi: 'Taarak Mehta Ka Ooltah Chashma' actor Gurucharan Singh, who had been missing for…
Bhubaneswar: Even as DGP has formed a Special Investigation Team (SIT) to investigate the death…
Agra: The Taj Mahal will never lose its significance and charm. Not without reason is the…
Bhubaneswar: Odisha had a special date with Neeraj Chopra as he landed at Biju Patnaik…
Rourkela: Ten years after losing the Lok Sabha electoral battle to former Union Tribal Affairs…
New Delhi: Stung by her own party AAP’s allegation that she was the face of…